CPRX (CPRX) EBITDA Margin: Latest Data, Historical Trends & Peer Comparison
What is CPRX's (CPRX) EBITDA Margin?
For the trailing twelve months (TTM) ended Mar 31, 2026, CPRX EBITDA Margin was 51.23%, representing a +1.76% change year over year.
For fiscal Q1'26 ended Mar 31, 2026, CPRX EBITDA Margin was 55.56%, representing a +7.9% change year over year.
EBITDA Margin Historical Trend for CPRX
View CPRX's annual, quarterly, and TTM EBITDA Margin data from 2018 to 2026, including historical growth rates and trend analysis.
CPRX TTM Data
| Metric | Q4'18Dec 31, 2018 | Q1'19Mar 31, 2019 | Q4'19Dec 31, 2019 | Q1'20Mar 31, 2020 | Q2'20Jun 30, 2020 | Q3'20Sep 30, 2020 | Q4'20Dec 31, 2020 | Q1'21Mar 31, 2021 | Q2'21Jun 30, 2021 | Q3'21Sep 30, 2021 | Q4'21Dec 31, 2021 | Q1'22Mar 31, 2022 | Q2'22Jun 30, 2022 | Q3'22Sep 30, 2022 | Q4'22Dec 31, 2022 | Q1'23Mar 31, 2023 | Q2'23Jun 30, 2023 | Q3'23Sep 30, 2023 | Q4'23Dec 31, 2023 | Q1'24Mar 31, 2024 | Q2'24Jun 30, 2024 | Q3'24Sep 30, 2024 | Q4'24Dec 31, 2024 | Q1'25Mar 31, 2025 | Q2'25Jun 30, 2025 | Q3'25Sep 30, 2025 | Q4'25Dec 31, 2025 | Q1'26Mar 31, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EBITDA Margin YoY | -7.05K% -- | -234.05% -- | 31.16% +100.44% | 36.61% +115.64% | 35.83% -- | 34.52% -- | 34.76% +11.57% | 33.78% -7.74% | 36.36% +1.47% | 36.27% +5.09% | 37.33% +7.39% | 39.08% +15.71% | 42.72% +17.49% | 44.03% +21.39% | 48.12% +28.9% | 49.86% +27.58% | 51.01% +19.43% | 28.78% -34.64% | 30.06% -37.54% | 27.72% -44.4% | 28.18% -44.75% | 45.92% +59.53% | 47.36% +57.57% | 50.35% +81.6% | 50.36% +78.67% | 51.29% +11.71% | 50.20% +5.98% | 51.23% +1.76% |
CPRX Quarterly Data
| Metric | Q4'18Dec 31, 2018 | Q1'19Mar 31, 2019 | Q2'19Jun 30, 2019 | Q3'19Sep 30, 2019 | Q4'19Dec 31, 2019 | Q1'20Mar 31, 2020 | Q2'20Jun 30, 2020 | Q3'20Sep 30, 2020 | Q4'20Dec 31, 2020 | Q1'21Mar 31, 2021 | Q2'21Jun 30, 2021 | Q3'21Sep 30, 2021 | Q4'21Dec 31, 2021 | Q1'22Mar 31, 2022 | Q2'22Jun 30, 2022 | Q3'22Sep 30, 2022 | Q4'22Dec 31, 2022 | Q1'23Mar 31, 2023 | Q2'23Jun 30, 2023 | Q3'23Sep 30, 2023 | Q4'23Dec 31, 2023 | Q1'24Mar 31, 2024 | Q2'24Jun 30, 2024 | Q3'24Sep 30, 2024 | Q4'24Dec 31, 2024 | Q1'25Mar 31, 2025 | Q2'25Jun 30, 2025 | Q3'25Sep 30, 2025 | Q4'25Dec 31, 2025 | Q1'26Mar 31, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EBITDA Margin YoY | -2.97K% -- | -7.82% -- | 38.03% -- | 44.83% -- | 26.67% +100.9% | 36.77% +569.93% | 34.83% -8.4% | 40.02% -10.72% | 27.85% +4.41% | 32.77% -10.88% | 43.64% +25.29% | 39.04% -2.47% | 33.35% +19.74% | 40.38% +23.23% | 53.86% +23.42% | 44.82% +14.81% | 51.71% +55.06% | 49.44% +22.44% | 55.50% +3.05% | -27.87% -162.19% | 45.98% -11.08% | 37.11% -24.95% | 51.90% -6.5% | 46.90% +268.28% | 50.98% +10.89% | 51.50% +38.77% | 51.69% -0.4% | 51.00% +8.74% | 46.77% -8.25% | 55.56% +7.9% |
CPRX (CPRX) : Definition & Explanation
EBITDA Margin shows how much of each dollar of revenue remains at a particular step of the income statement or cash flow profile.
It matters because ebitda margin can reveal pricing power, cost discipline, business mix, and whether growth is turning into real economic value.
This is usually a calculated ratio. The numerator is a profit or cash flow measure, and the denominator is revenue for the same period.
Investors often compare ebitda margin across time, against peers, and alongside revenue growth. A rising margin can be encouraging, but it is worth checking whether the change came from healthy operating improvement, temporary mix shifts, or one-off items.
CPRX (CPRX) EBITDA Margin Related Metrics
Explore key financial metrics related to CPRX's (CPRX) EBITDA Margin. Click on the links below to dive deeper into similar and complementary indicators.
About CPRX (CPRX)
CPRX
Industry
--
Established Date
--
Listing Date
--
Exchange
--
Full-time Employees
--
Fiscal Year Ends
--
Website
--
Security Type
--
Office address
--
Business
--
Introduction
--